NYSEMKT: TOVX
Theriva Biologics Inc Stock Ownership - Who owns Theriva Biologics?

Insider buying vs selling

Have Theriva Biologics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TOVX insiders and whales buy or sell their stock.

TOVX Shareholders

What type of owners hold Theriva Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc0.56%255,727$84.39kInstitution
Steven A. Shallcross0.54%250,000$82.50kInsider
Geode Capital Management LLC0.46%212,087$69.99kInstitution
Morgan Stanley0.44%200,000$66.00kInstitution
Ubs Group Ag0.42%191,410$63.17kInstitution
Ikarian Capital LLC0.24%112,076$36.99kInstitution
Two Sigma Securities LLC0.09%42,893$14.15kInstitution
Two Sigma Investments LP0.09%42,337$13.97kInstitution
Drw Securities LLC0.09%41,745$13.78kInstitution
Xtx Topco Ltd0.09%39,445$13.02kInstitution

1 of 3

TOVX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TOVX2.82%0.54%
ICU5.72%94.28%Net Buying
PASG4.08%95.92%Net Selling
LEXX6.86%3.30%Net Buying
GNTA11.58%0.27%

Theriva Biologics Stock Ownership FAQ

Who owns Theriva Biologics?

Theriva Biologics (NYSEMKT: TOVX) is owned by 2.82% institutional shareholders, 0.54% Theriva Biologics insiders, and 96.63% retail investors. Steven A. Shallcross is the largest individual Theriva Biologics shareholder, owning 250,000.00 shares representing 0.54% of the company. Steven A. Shallcross's Theriva Biologics shares are currently valued at $89.75k.

If you're new to stock investing, here's how to buy Theriva Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.